|
|
|||||||||
Dr. Chen is Fellow in Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA.
Dr. Iddings is Fellow in Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA.
Dr. Scheri is Fellow in Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA.
Dr. Bilchik is Director, Gastrointestinal Program; Director of Gastrointestinal Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA.
This article is available online at http://CAonline.AmCancerSoc.org
Since the introduction of sentinel node biopsy in 1990 as a minimally invasive surgical technique for the diagnosis of melanoma lymphatic metastases, the number of applications has expanded. We review applications and the current status of sentinel node biopsy in melanoma, breast, colon, gastric, esophageal, head and neck, thyroid, and lung cancer. Variations on techniques specific to each organ are explained, and the current role of sentinel node biopsy in diagnosis and treatment is discussed.
This article has been cited by other articles:
![]() |
R. P. Scheri, R. Essner, R. R. Turner, X. Ye, and D. L. Morton Isolated Tumor Cells in the Sentinel Node Affect Long-Term Prognosis of Patients with Melanoma Ann. Surg. Oncol., October 1, 2007; 14(10): 2861 - 2866. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |